Regulus Therapeutics Inc. (RGLS) Fell -8.16% or -0.02 To Price $0.18 On Monday


Regulus Therapeutics Inc. (RGLS) fell -8.16% or -0.02 to $0.18. It is about 871795 shares traded, which is 50.14% compare to the average total volume 1.74 million. The market cap of RGLS is $18.77 million. The year to date change is -90.91%. The 52 week price range is from $0.17 to $1.52. Price of RGLS have changed -8.33% during last week. It have changed -21.09% over last month, -71.76% over last 3 months, -76.80% over last 6 months and -85.35% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RGLS is 0.26. It is 44.44% above current price. The 200-day Moving Averages for RGLS is 0.74. It is 311.11% above current price. The 52-week High is 1.52. It is 744.44% from the current price. The 52-week Low is 0.17. It is -5.56% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of RGLS is 0.24 on 2018-08-31. Short % to float is 0.46%. There are some statistics of RGLS. It is has market cap $18.77 million. The share outstanding is 104.84 million. The average volume is 1.74 million. The revenue is 18000. The percent of top 15 Institution holding is 49.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RGLS is -395.35%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RGLS is -108.35%.


Tags:

Share this post